Polycystic ovarian syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, metformin tablets at a dose of 1500 mg plus melatonin at a dose of 3 mg are given twice a day for two months. Intervention 2: Control gro
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Women aged 18 to 40 years with infertility Diagnosis of Polycystic Ovary Syndrome (PCOS) confirmed according to Rotterdam criteria Normal hysterosalpingography Normal sperm analysis of the partner No history of benzodiazepine or anti-anxiety medication use
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number, size of follicles, and endometrial thickness. Timepoint: The size, number of follicles, and endometrial thickness are checked three times after the end of the treatment period, halfway through each menstrual cycle. Method of measurement: Transvaginal ultrasound is used to measure the number and size of follicles and the thickness of the endometrium. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: After a two-day delay in menstural period. Method of measurement: Beta- HCG blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehnaz Sovizi
Sabzevar University of Medical Sciences
Outcome results
None listed